Carregant...

Pneumothorax as a Complication of Combination Antiangiogenic Therapy in Children and Young Adults with Refractory/Recurrent Solid Tumors

PURPOSE: Antiangiogenic agents show significant antitumor activity against various tumor types. In a study evaluating the combination of sorafenib, bevacizumab, and low-dose cyclophosphamide in children with solid tumors, an unexpectedly high incidence of pneumothorax was observed. We evaluated pati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Pediatr Surg
Autors principals: Interiano, Rodrigo B., McCarville, M. Beth, Wu, Jianrong, Davidoff, Andrew M., Sandoval, John, Navid, Fariba
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4758326/
https://ncbi.nlm.nih.gov/pubmed/25783402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpedsurg.2015.01.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!